Decrease in Le(x) expression in esophageal adenocarcinomas arising in Barrett's epithelium

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 4, 1997, Pages 245-248

  Engel, Ulla ^a   McCombs, Ronda ^b   Stranahan, Patricia ^b   Pettijohn, David ^b   Hage, Esther ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BARRETT ESOPHAGUS; BLOOD GROUP LEWIS SYSTEM; CARDIA; CLINICAL ARTICLE; DYSPLASIA; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD15; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS;

EID: 0030895318     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Irimura, T. Cancer metastasis determined by carbohydrate-mediated cell adhesion. Adv. Exp. Med., 353: 27-34, 1994.
2. Pettijohn, D. E., Stranahan, P. L., Due, C., Ronne, E., Rahbek, S. H., and Olsson, L. Glycoproteins distinguishing non-small cell from small cell lung carcinoma recognized by monoclonal antibody 43-9F. Cancer Res., 47: 1161-1169, 1987.
3. x expression in esophageal adenocarcinomas arising in Barrett's epithelium. Proc. Am. Assoc. Cancer Res., 36: 587, 1995.
4. Visfeldt, J., Giwercman, A., and Skakkbaek, N. E. Monoclonal antibody 43-9F: an immunochemical marker of embryonal carcinoma of the testes. APMIS, 100: 63-70, 1992.
5. Dabelsteen, E., Mandel, U., and Clausen, H. Blood group antigens as differentiation and tumor associated markers in oral epithelium. Proc. Finn. Dent. Soc., 84: 19-29, 1988.
6. a-X oligosaccharides and excludes antibodies from the underlying cells. Cancer Res., 52: 2923-2930, 1992.
7. Clausen, H., and Hakomori, S. ABH and related histo-blood group antigens. Immunochemical differences in carrier isotypes and their distribution. Vox Sang, 56: 1-20, 1989.
8. Ogawa, H., Inoue, M., Tanizawa, O., Miyamoto, M., and Sakura, M. Altered expression of sialyl-TN, Lewis antigens and carcinoembryonic antigen between primary and metastatic lesions of uterine cervical cancers. Histochemistry, 97: 311-317, 1992.
9. Kobayashi, K., Sakamoto, J., Kito, T., Yamaura, Y., Koshikawa, T., Fujita, M., Watanabe, T., and Nakazato, H. Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma and gastric carcinoma. Am. J. Gastroenterol., 88: 919-924, 1993.
10. Battifora, H., Sorensen, H. R., Mehla, P., Ahn, C., Niland, J., Hage, E., Pettijohn, D. E., and Olsson, L. Tumor-associated antigen 43-9F is of prognostic value in squamous cell carcinoma of the lung. Cancer (Phila.), 70: 1867-1872, 1992.
11. 4 defined by monoclonal antibody 43-9F: enzymatic synthesis, structural characterization and comparative reactivity with various antibodies. Biochemistry, 33: 10672-10680, 1994.
12. Sell, S. Cancer-associated carbohydrates identified by monoclonal antibodies. Hum. Pathol., 21: 1003-1019, 1990.
13. Feizi, T. Demonstration by antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature (Lond.), 314: 53-57, 1985.
14. Itzkowitz, S. H. Carbohydrate changes in colon carcinoma. APMIS 100 (Suppl. 27): 173-180, 1992.
15. Hakomori, S. Aberrant glycosylation in tumors and tumor associated antigens. Adv. Cancer Res., 52: 257-331, 1989.
16. Cameron, A. J., Ott, B. J., and Payne, W. S. The incidence of adenocarcinoma in columnar lined (Barrett's) esophagus. N. Engl. J. Med., 313: 857-859, 1985.
17. Rusch, V. W., Levine, D. S., and Haggitt, R. The management of high grade dysplasia and early cancer in Barrett's esophagus. Cancer (Phila.), 74: 1225-1229, 1994.
18. Cassan, A. G., Mukhopadhyay, T., Cleary, J. A., Levin, B., and Roth, J. A. p53 mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51: 4495-4499, 1991.
19. Stranahan, P. L., Laroe, J. L., McCombs, R., Goldsmith, A., Rahim, I., Overland, M., and Pettijohn, D. E. Cell-cell interactions influence oligosaccharide modifications on mucins and other large glycoproteins, Glycoconj. J., 13: 741-747, 1996.
20. Hakomori, S. Introductory remarks on aberrant glycosylation in tumors. In: C. L. Reading, S. Hakomori, and D. M. Marcus (eds.), Altered Glycosylation in Tumor Cells, pp. 207-212. New York: Alan R. Liss, 1988.
21. x expression predict survival in patients with esophageal adenocarcinoma. Proc. Am. Assoc. Cancer Res., 36: 211, 1995.
22. Matsushita, Y., Cleary, K. A., Ota, D. M., Hoff, S. D., and Irimura, T. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab. Invest., 63: 780-791, 1990.
23. Davidson, J. S., and Triadofilopoulos, G. Blood group-related antigen expression in normal and metaplastic upper gastrointestinal mucosa. Gastroenterology, 103: 1552-1561, 1992.
24. Lauwers, G. Y., Malamed, I., and Rojas-Corona, R. R. Blood group antigens in Barrett's esophagus and associated adenocarcinomas. Mod. Pathol., 6: 588-591, 1993.